Updates to prescribing medicines in pregnancy database

22 Mar 2018

The Therapeutic Goods Administration (TGA) has recently added a number of new entries to the Prescribing Medicines in Pregnancy Database.

The new entries include the following:

  • baricitinib (pregnancy category D)
  • bezlotoxumab  (pregnancy category B2)
  • cabozantinib [as (S)-malate] (pregnancy category D)
  • dupilumab (pregnancy category B1)
  • fosfomycin trometamol (pregnancy category B2)
  • glecaprevir / pibrentasvir (pregnancy category B1)
  • iron [as ferric derisomaltose] (parenteral) (pregnancy category B3)
  • lixisenatide with insulin glargine (pregnancy category B3)
  • meningococcal group B vaccine (pregnancy category B1)
  • nusinersen (pregnancy category B1)
  • patiromer (as sorbitex calcium) (pregnancy category B1)
  • pegaspargase (pregnancy category D)
  • ribociclib (pregnancy category D)

The Australian categorisation system and database for prescribing medicines in pregnancy have been developed by medical and scientific experts based on available evidence of risks associated with taking particular medicines while pregnant. This information is intended for health professionals, including GPs, prescribing medicines to pregnant women.

You can access the TGA database here.